Fabio Ivankovich Email & Phone Number

São Paulo, Sp, Br

State Of São Paulo, Brazil

CEO of Genesis Genomics, a joint venture of Hospital Albert Einstein and Fleury

Thousand Oaks, Ca, Us

As a result of Amgen's acquisition of Horizon Therapeutics in October 2023, I am excited to share that I will continue my role leading Rare Disease BU in Brazil and supporting Rare Disease in LACAN Region

Dublin, Ireland, Ie

• Leading Regional and Country GMs focused on international expansion in European Countries, Saudi Arabia and Japan (with a total team of over 80 people), with regulatory submission and launch of UPLIZNA, for NMSOD, and TEPEZZA, for TED (rare disease)• Accumulating role of GM Brazil and Region LATAM and Canada. Launching UPLIZNA for NMOSD and TEPEZZA for TED (Thyroid Eye Disease) in Brazil (leading a team of 25 people) and preparing the launch of UPLIZNA in Canada

Dublin, Ireland, Ie

• Definition of business model and strategy for other LATAM Countries: Argentina and Colombia• Regulatory submission of 2 products (UPLIZNA and TEPEZZA) in Brazil (ANVISA) and Colombia (INVIMA). UPLIZNA was approved by ANVISA on December 26th, 2022 and TEPEZZA in June 2023• Business Plan for Regulatory submission and launching of UPLIZNA and TEPEZZA in Canada

Dublin, Ireland, Ie

• Led Horizon's startup in Brazil, Legal Entity, ANVISA`s License, establishing the office in Sao Paulo, working together with Headquarter in Deerfield – IL (USA)• Responsible for the definition of structure, planning (medium and long terms), hiring employees, local vendors, building the company's image in Brazil with several stakeholders and other actions

Dublin, Ireland, Ie

Led Horizon's startup in Brazil from scratch, starting with legal entity and Anvisa’s licenses, working together with Headquarter in IL (United States)

Cambridge, Ma, Us

• Led Sarepta's startup in Brazil from green field working together with Headquarter in Cambridge (United States).• Responsible for the definition of structure, planning (medium and long terms), hiring employees and vendors, building the company's image in Brazil with several stakeholders and other actions.• Spearheaded the construction of the company’s culture in Brazil engaging people. Sarepta was certified as a Great Place to Work (GPTW) in 2019 and 2020.• Built strategies for public access, regulatory, marketing, commercial, patient associations and government agencies.• Responsible for getting all licenses and registering medicines for rare diseases in the Brazilian market, including gene therapy preparation.• Each Step Matters – innovative project focused on DMD Disease Awareness and inclusion (partnership with Mauricio de Sousa Produções) engaging Patient Associations – strong PR Strategy with a huge repercussion (more than 500 million impacts in 2019).

Tokyo, Jp, Jp

• Responsible for a structure with 26 people, including Product Manager, Marketing Assistant, Sales Managers and Sale Representatives.• Neuroscience – ADHD:o Venvanse – repositioning of product strategy, focused on market leadership. In 2014, 3rd market share in Brazil. In 2016, reached leadership in value and units (YTD). In 2017, YTD market share: 48.8% (units); 56.2% (value).o Commercial strategy and negotiation with wholesalers and Pharmacy chain.o Management of own events and negotiation on Medical events (national and international).o BI – market research to identify new opportunities to grow.o New approach for Field Force based on the storytelling concept.o Launch plan for Guanfacina in Brazil (non-stimulant medicine for ADHD) and new indication of Venvanse (BED - Binge Eating Disorder).• Gastrointestinal / Internal Medicine:o Launch plan for a product focused on Hypoparathyroidism and another one for Short Bowel Syndrome (both, rare diseases) – market research (BI) working together with Medical Affairs identifying KOLs and establishing a disease awareness plan, business case with long term forecast (P&L), timeline to launch, patient journey, access strategy considering public and private markets.• Ophthalmic:o Launch plan for Xiidra in Brazil for dry eye disease mapping the market (BI), establishing a long-term plan, considering P&L and all marketing and commercial strategies (access public and private).

Switzerland 🇨🇭 , Ch

• Responsible for a structure with 130 people including Product Managers, Marketing Coordinators, Sales Managers and Representatives.• Led a project focused on Public Market (access) - MabThera and Actemra for the treatment of Rheumatoid Arthritis and Pegasys for Hepatitis C (centralized purchase by the Ministry of Health).o Resulted in sales to the Ministry of Health for Rheumatoid Arthritis Products and growth of 30% of quantities purchased for Hepatitis C from 2013 to 2014.• Led the strategy for mature products such as Prolopa (Parkinsons), Pulmozyme (Fibrosis) and Valcyte (Transplants).o Maintenance of Prolopa sales growth in 2013 even with the launch of a generic competitor as well as 2-digit sales growth of Pulmozyme and Valcyte.• Reorganized internal and sales force structures.o More effectiveness with cost control.

Switzerland 🇨🇭 , Ch

• Responsible for a new Business Unit at Roche Brazil with 2 Product Managers, 2 Marketing Coordinators, 1 National Sales Manager, 4 Territory Managers, and 23 Sales Representatives.• Established a strategy for two different biologic products (MabThera and Actemra) focused on the same disease (Rheumatoid Arthritis). Negotiation with Oncology and Rheumatology Infusion Centers.o Resulted in a clear and differentiated positioning for each product – Actemra sales grew 50% in 2012 versus 2011 and over 80% in 2013 versus 2012.• Led people management project focused on increasing employee engagement.o In a Global Survey (GEOS – Global Employee Opinion Survey), the BU reached 91% in 2011 in terms of engagement (Roche Brazil engagement was 72%) and, in 2013, the BU reached 100% of engagement.• Member of the Management Team working on the new structure of Roche Brazil and new procedures focused on marketing, access, segmentation, and corporate engagement.o Resulted in a cultural change and increased the level of employee engagement. For the first time ever, Roche was on Brazil’s "Top 100" of GPTW (Great Places to Work) list for 2012, rising to position number 30 in 2013.

Switzerland 🇨🇭 , Ch

• Acting in the price registration review process for Zelboraf (Oncology) - CMED

Switzerland 🇨🇭 , Ch

• Led the startup of RA Structure building an RA franchise in Brazil, with MabThera RA, pre-launching activities for Actemra, and hiring the Sales Force and Marketing team.o Annual sales growth of MabThera in Rheumatoid exceeded 50% and Rheumatologists’ awareness of Actemra’s new mechanism of action (IL-6) rose above 80%.

Switzerland 🇨🇭 , Ch

• Responsible for 8 Territorial Managers and more than 70 sales representatives, focused on Bonviva and Xenical.o Bonviva – 2nd position in 12 months (more than 30% market share – Brazilian Original Bisphosphonates Market).o Xenical – protection against launch of generic sibutramine, maintaining the same level of sales.

Switzerland 🇨🇭 , Ch

• Set strategy and implemented Bonviva Brand Plan in Brazil. Pre-launch and launch in May 2006.o Resulted in one of the best Bonviva market shares in the world: over 30%.• Central Nervous System - Managed Lexotan, Prolopa and Rivotril drawing up strategy to launch a new formulation for Lexotan (Lexotan drops) and Rivotril (sublingual), plus a protection strategy considering generic competition.o Stabilization of Lexotan sales and growth of Rivortil for new indications: panic and vertigo.• Managed the post-launch of Tamiflu.• Managed mature products including Bactrim, Rocaltrol, and Rocefin.

Switzerland 🇨🇭 , Ch

• Restructured an “in-house agency” and managed the Promotional Materials Warehouse with 15 subordinates.• Led the process reducing by approximately 50% external promotion agency costs and increased quality control of printed materials, thereby reducing reprints costs.

Marketing Strategy and Sales Manager

Br

Sao Paulo, São Paulo, Br

Negotiation with suppliers; managing art designers

Clients like Nestle, Unilever, Seagram

Master Of Business Administration (M.B.A.), Executive Mba

Bachelor'S Degree, Social Communication -

Executive Mba - Marketing Champions Programme - 5 Days, 45 Hours

Ensino Médio Completo